Position in ENTA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$232,315
-$634,861 QoQ
Shares Held
18,394
-66.5% QoQ
Ownership
0.063%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ENTA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026BARCLAYS PLC holds $1,494,145,056 across 362 Biotechnology names. ENTA ranks #207 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
663,263 | $296,173,457 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
313,093 | $241,908,173 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
220,623 | $72,997,531 | |
| 4 | MRNA |
Moderna, Inc.
|
932,269 | $47,359,264 | |
| 5 | INSM |
INSMED Inc
|
275,731 | $45,087,531 | |
| 6 | ROIV |
Roivant Sciences Ltd.
|
1,415,848 | $39,218,988 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
383,179 | $37,264,156 | |
| 8 | TERN |
Terns Pharmaceuticals, Inc.
|
669,601 | $35,301,364 |
All Filings in ENTA
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $232,315 | 18,394 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $867,176 | 54,989 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $498,203 | 41,621 | Shares | Sole | 2026-03-31 | |
| 2025-06-30 | $362,033 | 47,888 | Shares | Sole | 2026-02-27 | |
| 2025-03-31 | $195,325 | 35,385 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $261,671 | 45,508 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $284,257 | 27,438 | Shares | Sole | 2024-11-19 | |
| 2024-06-30 | $90,271 | 6,960 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $246,535 | 14,120 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $388,633 | 41,300 | Shares | Sole | 2024-02-15 | |
| 2023-09-30 | $192,336 | 17,219 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $1,089,345 | 50,904 | Shares | Sole | 2023-09-20 | |
| 2023-03-31 | $1,061,549 | 26,250 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $2,367,821 | 50,899 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $2,353,238 | 45,368 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $274,024 | 5,797 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $1,065,563 | 14,970 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,872,341 | 25,038 | Shares | Sole | 2022-02-23 | |
| 2021-09-30 | $1,292,825 | 22,757 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $493,352 | 11,210 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $1,160,844 | 23,537 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $1,042,816 | 24,770 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $1,200,855 | 26,231 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $902,574 | 17,976 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $759,363 | 14,765 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||